Singapore's Deputy Prime Minister Heng Swee Keat and the delegation observed and experienced the pro

Recently, Singapore Deputy Prime Minister and Coordinating Minister for Economic Policies Heng Swee Keat and a senior delegation from the Singapore government started a multi-day visit to China. The first stop was Beijing, where they visited Tsinghua Science Park and exchanged views with Wang Jiwu, Chairman of TusHoldings, on topics such as technological innovation. The trip focused on visiting representative companies incubated and invested by Tsinghua and TusHoldings, such as Tupai Medical.

Mr. Zhou Jian, Vice President of International Affairs of Tupai Medical, gave a detailed introduction to Deputy Prime Minister Heng Swee Keat on the company's background and growth history, as well as the characteristics and breakthroughs of OCT in the clinical and technical fields. Professor Huang Tianyin, a member of the National Academy of Sciences of Singapore and Director of the School of Medicine of Tsinghua University, who accompanied the visit, also analyzed the significance and importance of the new generation of OCT developed by Tupai in the field of ophthalmology from a professional perspective.

Vice President of Tupai Medical, Zhou Jian, introduced OCT technology to Deputy Prime Minister Heng Swee Keat

Deputy Prime Minister Heng Swee Keat highly praised the rapid technological progress of Tupai Medical's products, which have far surpassed the world's mainstream brands in terms of performance. The company's technological leap and industry status in just over six years since its establishment reflect the extraordinary speed of China. The proportion of Tupai's products that are highly self-developed and self-made in terms of parts is impressive. We look forward to Tupai Medical's equipment completing the registration and certification of the Singapore Health Sciences Authority as soon as possible, and providing world-class technical services to Singapore's medical staff and patients.

Deputy Prime Minister Heng Swee Keat posted a picture of his visit to Tupai Medical Equipment on his personal social media account summarizing the achievements of the first day of his visit to China.

Tupai Medical's core technology originated from the transformation of Tsinghua's achievements and was cultivated and incubated by Tsinghua Industrial Technology Research Institute. The core technology team consists of dozens of teachers and students from multiple disciplines of Tsinghua. Since its establishment, Tupai Medical has completed 7 rounds of financing with a total amount of nearly 800 million yuan and an annual R&D investment of nearly 100 million yuan. The company has six major high-end ophthalmic equipment pipelines, among which ophthalmic OCT products ranked first in the total amount and average bid price of 2023 in the Chinese public hospital market*.

① Sullivan Consulting "Blue Book on the Current Status and Future Development Trends of High-end Ophthalmic Medical Equipment Industry" (April 2024)